Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,876.00
(
0.02%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.01
(
4.78%
)
Bitcoin
75,832.80
(
-0.08%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: biopharm post# 268522

Monday, 07/25/2016 10:16:20 AM

Monday, July 25, 2016 10:16:20 AM

Post# of 347009
Let the investigations begin...
http://www.bbc.com/news/uk-wales-south-east-wales-35797148

Parsa ... Thorpe....how many more are tied to disruptive paradigm shifts in biotech and all of a sudden, pass on...

Peregrine Pharmaceuticals and PS Targeting is as disruptive as it gets

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote